Armand Sprecher

So they're probably not off by an order of magnitude, but they're not going to be on the money.

But at any rate, we can follow those, and hopefully when diagnostics show up, we'll come up with better numbers.

It is.

It is.

There is an existing vaccine for Ebola virus that might have some activity against Mundibokyo virus.

And I think right now the WHO is a little bit concerned that it's not good enough.

But there is a significant amount of that if it gets brought to bear.

Even if it is partially effective, that's better than nothing.

And we at least know that it's a safe vaccine.

There's therapeutic options that we're going to be testing very shortly.

And if those work, we hope to bring them to bear as well.

So there's a clinical trial in the works that should get started.

That's a step ahead of the vaccine because we already know that those work in animal models.